GSK-BRL-029060/329: Acute Phase

A Multi-center, Double-blind, Placebo-Controlled Study of Paroxetine and Imipramine in Adolescents with Unipolar Major Depression - Acute Phase
BRL-029060/329: Acute Phase
Depressive Disorder
Phase 3
This study was conducted in 2 phases - an acute phase and a continuation phase. A comprehensive dataset for the complete study is available. The data from this study is provided in a combined datasets containing data from other paroxetine studies. An annotated case report form is not available for this study. A blank case report form will be provided. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
January 2014